Skip to main content
logo
Neuren Pharmaceuticals Limited (ASX:NEU)
Australia flag Australia · Delayed Price · Currency is AUD
20.45
-0.57 (-2.71%)
Aug 28, 2026, 4:10 PM AEST

Neuren Pharmaceuticals Cash Flow Statement

Millions AUD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
20.2630.44142.04157.080.18-7.79
Depreciation & Amortization
0.030.020.020.020.010.01
Loss (Gain) From Sale of Investments
5.383.3-3.591.530.7-
Stock-Based Compensation
4.83.671.232.931.990.84
Other Operating Activities
-6.91-8.0310.440.140.18-0.4
Change in Accounts Receivable
1.06154.59-157.11-13.110.19-2.51
Change in Accounts Payable
0.51-0.49-0.48-0.34-0.11
Change in Income Taxes
-14.32-48.91-3.8336.35--
Change in Other Net Operating Assets
-9.82-9.17----
Operating Cash Flow
5.12125.42-11.27184.933.6-9.97
Operating Cash Flow Growth
-96.28%--5038.23%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.04-0.04-0.01-0.04-0.02-0.01
Investment in Securities
16.42-87.974.14-211.45--
Investing Cash Flow
16.38-88.014.13-211.49-0.02-0.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
6.736.391.663.64-23.28
Repurchase of Common Stock
-3.88-39.57-10.43---
Other Financing Activities
-0.03-0.04-0.01-0.02-0-1.11
Financing Cash Flow
2.83-33.22-8.783.62-022.18

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-3.28-3.121.97-0.15-0.180.4
Net Cash Flow
21.041.07-13.94-23.093.412.6

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
5.08125.39-11.28184.893.58-9.98
Free Cash Flow Growth
-96.31%--5064.39%--
Free Cash Flow Margin
7.30%193.95%-5.20%79.71%23.22%-312.17%
Free Cash Flow Per Share
0.040.96-0.091.410.03-0.08
Levered Free Cash Flow
-13.55116.98-42.25152.972.59-6.76
Unlevered Free Cash Flow
-13.55116.98-42.25152.972.59-6.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
13.3354.1537.22-0.88-1.39-2.52
Change in Working Capital
-18.4496.02-161.4223.240.53-2.62